Literature DB >> 21775705

Endothelium-derived GM-CSF influences expression of oncostatin M.

Wafa M Elbjeirami1, Elizabeth M Donnachie, Alan R Burns, C Wayne Smith.   

Abstract

During and after transendothelial migration, neutrophils undergo a number of phenotypic changes resulting from encounters with endothelium-derived factors. This report uses an in vitro model with human umbilical vein endothelial cells and isolated human neutrophils to examine the effects of two locally derived cytokines, granulocyte (G)-macrophage (M) colony-stimulating factor (GM-CSF) and G-CSF, on oncostatin M (OSM) expression. Neutrophils contacting activated HUVEC expressed and released increased amounts of oncostatin M (OSM), a proinflammatory cytokine known to induce polymorphonuclear neutrophil adhesion and chemotaxis. Neutrophil transendothelial migration resulted in threefold higher OSM expression and protein levels compared with nontransmigrated cells. Addition of anti-GM-CSF neutralizing antibody reduced OSM expression level but anti-G-CSF was without effect. GM-CSF but not G-CSF protein addition to cultures of isolated neutrophils resulted in a significant increase in OSM protein secretion. However, inhibition of β(2) integrins by neutralizing antibody significantly reduced GM-CSF-induced OSM production indicating this phenomenon is adhesion dependent. Thus cytokine-stimulated endothelial cells can produce sufficient quantities of GM-CSF to influence in an adhesion-dependent manner, the phenotypic characteristics of neutrophils resulting in the latter's transmigration. Both transmigration and adhesion phenomenon lead to increased production of OSM by neutrophils that then play a major role in inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775705      PMCID: PMC3191567          DOI: 10.1152/ajpcell.00205.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  46 in total

1.  Subcellular fractionation of human neutrophils on Percoll density gradients.

Authors:  L Kjeldsen; H Sengelov; N Borregaard
Journal:  J Immunol Methods       Date:  1999-12-17       Impact factor: 2.303

2.  Early differential expression of oncostatin M in obstructive nephropathy.

Authors:  Wafa M Elbjeirami; Luan D Truong; Ahmad Tawil; Wansheng Wang; Sara Dawson; Hui Y Lan; Ping Zhang; Gabriela E Garcia; C Wayne Smith
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

3.  Activation of human neutrophil by cytokine-activated endothelial cells.

Authors:  T Takahashi; F Hato; T Yamane; H Fukumasu; K Suzuki; S Ogita; Y Nishizawa; S Kitagawa
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

4.  Oncostatin M production by blood and alveolar neutrophils during acute lung injury.

Authors:  A Grenier; D Combaux; J Chastre; M A Gougerot-Pocidalo; C Gibert; M Dehoux; S Chollet-Martin
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

5.  Granulocyte colony-stimulating factor promotes adhesion of neutrophils.

Authors:  Arup Chakraborty; Eric R Hentzen; Scott M Seo; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2002-09-18       Impact factor: 4.249

6.  Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils.

Authors:  P K Epling-Burnette; Roy Garcia; Fanqi Bai; Sajid Ismail; Thomas P Loughran; Julie Y Djeu; Richard Jove; Sheng Wei
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

7.  Exclusive neutrophil recruitment with oncostatin M in a human system.

Authors:  S M Kerfoot; E Raharjo; M Ho; J Kaur; S Serirom; D M McCafferty; A R Burns; K D Patel; P Kubes
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 8.  The signaling pathways induced by neutrophil-endothelial cell adhesion.

Authors:  Qin Wang; Claire M Doerschuk
Journal:  Antioxid Redox Signal       Date:  2002-02       Impact factor: 8.401

9.  Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.

Authors:  Suzanne M Hurst; Rachel M McLoughlin; James Monslow; Sara Owens; Llinos Morgan; Gerald M Fuller; Nicholas Topley; Simon A Jones
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

10.  Differential roles for alpha(M)beta(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms.

Authors:  B B Whitlock; S Gardai; V Fadok; D Bratton; P M Henson
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

View more
  9 in total

Review 1.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

2.  Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis.

Authors:  Hendra Setiadi; Tadayuki Yago; Zhenghui Liu; Rodger P McEver
Journal:  Blood Adv       Date:  2019-01-22

3.  Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

Authors:  Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2016-12-18       Impact factor: 10.793

4.  Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.

Authors:  Kavita Bisht; Crystal McGirr; Seo-Youn Lee; Hsu-Wen Tseng; Whitney Fleming; Kylie A Alexander; Taichi Matsumoto; Valérie Barbier; Natalie A Sims; Gerhard Müller-Newen; Ingrid G Winkler; Halvard Bonig; Jean-Pierre Lévesque
Journal:  Leukemia       Date:  2021-09-13       Impact factor: 11.528

5.  Polymorphonuclear Neutrophils and Tumors: Friend or Foe?

Authors:  Izabela Szulc-Kielbik; Magdalena Klink
Journal:  Exp Suppl       Date:  2022

6.  Oncostatin M: a Potential Biomarker to Predict Infection in Patients with Left Ventricular Assist Devices.

Authors:  Hendra Setiadi; Ahmed M El-Banayosy; Susan George; David W Schmidtke; Aly El-Banayosy; Douglas A Horstmanshof; James W Long
Journal:  ASAIO J       Date:  2021-11-10       Impact factor: 3.826

7.  Resveratrol Downregulates Granulocyte-Macrophage Colony-Stimulating Factor-Induced Oncostatin M Production through Blocking of PI3K/Akt/NF-κB Signal Cascade in Neutrophil-like Differentiated HL-60 Cells.

Authors:  Na-Ra Han; Hi-Joon Park; Phil-Dong Moon
Journal:  Curr Issues Mol Biol       Date:  2022-01-22       Impact factor: 2.976

8.  Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer's disease mice.

Authors:  De S Shang; Yi M Yang; Hu Zhang; Li Tian; Jiu S Jiang; Yan B Dong; Ke Zhang; Bo Li; Wei D Zhao; Wen G Fang; Yu H Chen
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

9.  Dexamethasone Attenuates Oncostatin M Production via Suppressing of PI3K/Akt/NF-κB Signaling in Neutrophil-like Differentiated HL-60 Cells.

Authors:  Na-Ra Han; Seong-Gyu Ko; Hi-Joon Park; Phil-Dong Moon
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.